Literature DB >> 15494497

CD4 phosphorylation partially reverses Nef down-regulation of CD4.

Yong-Jiu Jin1, Xiaoping Zhang, J Gildade Boursiquot, Steven J Burakoff.   

Abstract

HIV Nef down-regulates CD4 from the cell surface in the absence of CD4 phosphorylation, whereas PMA down-regulates CD4 through a phosphorylation-dependent pathway. In this study we show that the down-regulation of CD4 in human Jurkat T cells expressing Nef was nearly complete (approximately 95%), whereas that induced by PMA was partial (approximately 40%). Unexpectedly, treating T cells expressing Nef with PMA restored the surface CD4 up to 35% of the steady state level. Both mutating the phosphorylation sites in the CD4 cytoplasmic tail (Ser408 and Ser415) and the use of a protein kinase C inhibitor, bisindolylmaleimide1, abolished the restoration of surface CD4, suggesting that the restoration required CD4 phosphorylation. CD4 and Nef could be cross-linked by a chemical cross-linker, 3,3-dithiobis[sulfosuccinimidyl-propionate], in control T cell membranes, but not in PMA-treated T cell membrane, suggesting that CD4 and Nef interacted with each other in T cells, and the phosphorylation disrupted the CD4-Nef interaction. We propose that this dissociation switches CD4 internalization from the Nef-mediated, nearly complete down-regulation to a phosphorylation-dependent, partial down-regulation, resulting in a net gain of CD4 on the T cell surface.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494497     DOI: 10.4049/jimmunol.173.9.5495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

Review 2.  Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways.

Authors:  Jeremiah F Roeth; Kathleen L Collins
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

3.  Alkylating HIV-1 Nef - a potential way of HIV intervention.

Authors:  Yong-Jiu Jin; Xiaoping Zhang; Catherine Yi Cai; Steven J Burakoff
Journal:  AIDS Res Ther       Date:  2010-07-26       Impact factor: 2.250

4.  Nef-induced CD4 endocytosis in human immunodeficiency virus type 1 host cells: role of p56lck kinase.

Authors:  Nadine Laguette; Christelle Brégnard; Jérôme Bouchet; Alexandre Benmerah; Serge Benichou; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

5.  Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity.

Authors:  Shahnawaz Imam; Rodis Paparodis; Deepak Sharma; Juan Carlos Jaume
Journal:  Endocr Relat Cancer       Date:  2014-03-12       Impact factor: 5.678

6.  Proteomic-based identification of CD4-interacting proteins in human primary macrophages.

Authors:  Rui André Saraiva Raposo; Benjamin Thomas; Gabriela Ridlova; William James
Journal:  PLoS One       Date:  2011-04-13       Impact factor: 3.240

7.  Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation.

Authors:  Kurt Vermeire; Thomas W Bell; Victor Van Puyenbroeck; Anne Giraut; Sam Noppen; Sandra Liekens; Dominique Schols; Enno Hartmann; Kai-Uwe Kalies; Mark Marsh
Journal:  PLoS Biol       Date:  2014-12-02       Impact factor: 8.029

8.  HIV-1 Nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner.

Authors:  Sergio Castro-Gonzalez; Yuhang Shi; Marta Colomer-Lluch; Ying Song; Kaitlyn Mowery; Sharilyn Almodovar; Anju Bansal; Frank Kirchhoff; Konstantin Sparrer; Chengyu Liang; Ruth Serra-Moreno
Journal:  Autophagy       Date:  2020-02-25       Impact factor: 16.016

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.